Andrew B. Gladden

Statistics

Publications

Citations

1.9K

H-Index

Active since

2002

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Pennsylvania

UPMC Hillman Cancer Center

Cancer Research Institute

The University of Texas Health Science Center at Houston

Andrew B. Gladden is an author at The University of Texas MD Anderson Cancer Center specializing in life sciences, cell biology, and molecular biology.

ORCID

Publications per year

2002–2021

Publications

<i>Nf2</i> /Merlin controls progenitor homeostasis and tumorigenesis in the liver

Samira Benhamouche, Marcello Curto, Ichiko Saotome et al. · Genes & Development · 2010 · 287 citations · Full text

Medicine, Molecular Biology, Oncology +17

An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.

Fengmin Lu, Andrew B. Gladden, J. Alan Diehl · PubMed · 2003 · 240 citations

Life Sciences, Cell Biology, Oncology +12

p21Cip1 Promotes Cyclin D1 Nuclear Accumulation via Direct Inhibition of Nuclear Export

Jodi R. Alt, Andrew B. Gladden, J. Alan Diehl · Journal of Biological Chemistry · 2002 · 199 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

The NF2 Tumor Suppressor, Merlin, Regulates Epidermal Development through the Establishment of a Junctional Polarity Complex

Andrew B. Gladden, Alan M. Hebert, Eveline E. Schneeberger et al. · Developmental Cell · 2010 · 171 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +16

Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity

Michał Marzec, Monika Kasprzycka, Raymond Lai et al. · Blood · 2006 · 147 citations · Full text

Life Sciences, Cell Biology, Oncology +16

1–5 of 18